SINGH SHAWN (CHIEF EXECUTIVE OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2022ACC: 0001415889-22-000034
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Aug 2018
+3.62K
Net shares
Net buyer
$6.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
3.62K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.62K
Price / share
$1.66
Trade value
$6.01K
% of position
8.0%
12/31/2021
45.38K→49K
Total
Net shares
+3.62K
Net value
$6.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2021 | A · Award | +3.62K | $1.66 | $6.01K | 8.0% | 45.38K | 49K |
| Total | +3.62K | $6.01K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned26.23K
Total
26.23K indirect26.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 26.23K | Indirect |
| Total | 26.23K | 26.23K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported